Why the study?
Do Ca2+-antagonists and calmodulin inhibitors affect Sendai virus-mediated cell permeability changes?
Do Ca2+-antagonists and calmodulin inhibitors affect Sendai virus-mediated cell permeability changes?
Answers are grounded in this paper and cite their sources.
Calmodulin may be involved in protecting cells against virally-mediated membrane damage, or the action of calmodulin-binding drugs may be less specific than currently thought.
Sendai virus-mediated permeability changes in cells are affected by extracellular Ca2+ or Mn2+ as follows: the lag period to onset of permeability changes is lengthened and the subsequent extent of leakage is reduced. Drugs that block Ca2+ action in excitable cells, such as verapamil and prenylamine, and drugs that inhibit the action of calmodulin, such as trifluoperazine and R24571, have an effect opposite to that of Ca2+: lag is shortened and extent of leakage is increased. The concentration at which either type of drug shows 50% of maximal effect is similar to the concentration at which 50% of binding by drug to calmodulin is achieved. It is concluded that calmodulin may be involved in protecting cells against virally-mediated membrane damage; alternatively the action of calmodulin-binding drugs may not be as specific as currently thought.
No takes yet. Share an insight, caveat, or question.
Micklem et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: